| Price | 9.15p on 23-04-2026 at 18:50:08 |
|---|---|
| Change | -0.10p -1.08% |
| Buy | 9.30p |
| Sell | 9.00p |
| Last Trade: | Buy 93,301.00 at 9.30p |
| Day's Volume: | 489,621 |
| Last Close: | 9.15p |
| Open: | 9.25p |
| ISIN: | GB00BYV81293 |
| Day's Range | 9.15p - 9.25p |
| 52wk Range: | 2.25p - 12.35p |
| Market Capitalisation: | £97.76m |
| VWAP: | 9.138414p |
| Shares in Issue: | 1.07b |
Sector: Medicine and Biotech
Listed In: FTSE AIM All-Share,
Shield Thera (STX) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Buy* | 93,301 | 9.30p | Ordinary |
16:13:19 - 23-Apr-26 |
| Sell* | 11,013 | 9.00p | Ordinary |
16:11:28 - 23-Apr-26 |
| Buy* | 258 | 9.30p | SI Trade |
16:08:18 - 23-Apr-26 |
| Buy* | 81 | 9.30p | SI Trade |
16:08:18 - 23-Apr-26 |
| Sell* | 65,980 | 9.08p | Ordinary |
16:07:41 - 23-Apr-26 |
| Sell* | 6,301 | 9.08p | Ordinary |
16:00:33 - 23-Apr-26 |
| Sell* | 50 | 9.00p | Ordinary |
15:59:14 - 23-Apr-26 |
| Sell* | 11,013 | 9.08p | Ordinary |
15:53:10 - 23-Apr-26 |
| Buy* | 14 | 9.30p | SI Trade |
15:39:41 - 23-Apr-26 |
| Buy* | 112 | 9.30p | Ordinary |
15:18:17 - 23-Apr-26 |
Shield Thera (STX) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 9th Apr 2026 12:30 pm | RNS | Audited results for year ended 31 December 2025 |
| 1st Apr 2026 9:22 am | RNS-R | Publication of Report, Reinforcing FDA Approval |
| 31st Mar 2026 7:03 am | RNS | Total Voting Rights |
| 31st Mar 2026 7:00 am | RNS | EMA approves extension - to include adolescents |
| 3rd Mar 2026 7:00 am | RNS | Chinese NMPA Accepts MAA Submission for ACCRUFeR® |
| 27th Feb 2026 7:00 am | RNS | Total Voting Rights |
| 9th Feb 2026 7:00 am | RNS | FDA Grants additional Exclusivity for ACCRUFeR |
| 30th Jan 2026 7:05 am | RNS | Total Voting Rights |
| 30th Jan 2026 7:00 am | RNS | Approval for ACCRUFeR in China expected in Q1 2026 |
| 21st Jan 2026 7:00 am | RNS | Q4 2025 Trading Update |
